Copenhagen, Denmark, 19 December 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in precision cancer sur...
Copenhagen, Denmark, 27 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 3...
Copenhagen, Denmark, 25 November 2025 – FluoGuide A/S, a biotech company specializing in precision cancer surgery, announces a signed collab...
Copenhagen, Denmark, 24 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company” held an extraordinary general meeting on 24 November 202...
FluoGuide A/S will publish its Interim Report Q3 2025 on Thursday 27 November 2025.
Copenhagen, Denmark 4 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in precision cancer surge...
Copenhagen, Denmark 4 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders to participate in an extraord...
Copenhagen, Denmark, 3 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) announces that it has issued 199,000 warrants to members...
FluoGuide A/S announces that two of its shareholders, both of whom hold management and/or board positions in the Company, have entered into ...
Copenhagen, Denmark, 3 November 2025. FluoGuide A/S (“FluoGuide” or the “Company”) has, in accordance with the Company’s press release earli...
Copenhagen, Denmark, 3 November 2025. FluoGuide A/S (“FluoGuide” or the “Company”) announces its intention to carry out a directed share iss...
Copenhagen, Denmark, 28 October 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in precision cancer surg...
Copenhagen, Denmark, 6 October 2025 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company maximizing surgical out...
Copenhagen, Denmark, 16 September 2025 – FluoGuide A/S ("FluoGuide" or the "Company") received positive feedback and alignment with the FDA ...
Copenhagen, Denmark, 28 August 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 30 ...
FluoGuide A/S will publish its Interim Report Q2 2025 on Thursday 28 August 2025.
Copenhagen, Denmark, 21 July 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in precision cancer surgery...
Copenhagen, Denmark, 3 July 2025 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision cance...
Copenhagen, Denmark – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision cancer surgery, is...
Copenhagen, Denmark, 28 May 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 31 Mar...
Copenhagen, Denmark – FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery, is pleased t...
Copenhagen, Denmark, 27 March 2025 – FluoGuide A/S (“FluoGuide” or the “Company” held its annual general meeting on 27 March 2025.
Notice of Annual General Meeting in FluoGuide A/S
Copenhagen, Denmark, 27 February 2025 - FluoGuide A/S (“FluoGuide” or the “Company”) hereby publishes its annual report for the fiscal year ...
Copenhagen, Denmark, 27 February 2025 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January 202...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in precision cancer surgery, announces ap...
Copenhagen, Denmark, 27 November 2024 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January 202...
Copenhagen, Denmark, 19 November 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce publication of the first clinica...
Copenhagen, Denmark, 12 November 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) announces issuing of 37,500 warrants to board member Do...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in precision cancer surgery, announces t...
Copenhagen, Denmark - FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in precision cancer surgery, today annou...
Copenhagen, Denmark, 29 August 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 30 ...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in precision cancer surgery, announces th...
Copenhagen, Denmark, 18 June 2024. FluoGuide A/S, a developer of surgical precision solutions within oncology (“FluoGuide” or the “Company”)...
Copenhagen, Denmark, 30 May 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 31 Mar...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in precision cancer surgery, has chosen l...
Copenhagen, Denmark, 20 March 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general meeting on 20 March 2024.
Copenhagen, Denmark – 13 March 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) today announces that Ole Larsen (CFO) has bought shares.
FluoGuide enters collaboration within robot assisted head and neck cancer surgery with Intuitive Surgical, a world leading robotic-assisted ...
FluoGuide A/S publishes year-end and annual report for the fiscal year 2023
FluoGuide A/S issues warrants to CFO
FluoGuide provides strategic update and outlines development plans towards commercialization of FG001
Copenhagen, Denmark, 9 December 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today announces that Grethe Nørskov Rasmussen (CDO) has ...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field of precision cancer surgery, today a...
Copenhagen, Denmark, 29 November 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 3...
FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer
FluoGuide confirms positive topline results from phase lla trial of FG001 in head & neck cancer at International Academy of Oral Oncology co...
FluoGuide receives FDA Orphan Drug Designation for FG001 in high-grade glioma
Copenhagen, Denmark, 8 September 2023 – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field of precision cance...
Copenhagen, Denmark, 7 September 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to see the first data from FG001 study guidi...
Copenhagen, Denmark, 30 August 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 30 ...
FluoGuide reports further positive interim data from phase IIa trial of FG001 in head & neck cancer
FluoGuide completes patient enrollment and treatment in FG001 phase llb clinical trial in aggressive brain cancer
Copenhagen, Denmark, 28 August 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the issue of 211,389 warrants...
Copenhagen, Denmark, 31 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that based on the approved Incentive...
Copenhagen, Denmark, 25 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held an extraordinary general meeting on 25 July 2023.
Copenhagen, Denmark, 7 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders to participate in an extraordina...
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery, is pleased to announce that t...
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery, is pleased to announce positi...
Copenhagen, Denmark, 31 May 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 31 Mar...
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery, is pleased to provide an upda...
FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that Innovation Fund Denmark (Innovationsfonden) has awarded its largest...
Copenhagen, Denmark, 21 March 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general meeting on 21 March 2023.
FluoGuide A/S (“FluoGuide” or the “Company”) hereby publishes its annual report for the fiscal year 2022.
FluoGuide A/S (“FluoGuide” or the “Company”) provides an update on the clinical timelines for the ongoing clinical phase IIb trial of FG001 ...
FluoGuide A/S (“FluoGuide” or the “Company”) has appointed Ole Larsen as Chief Financial Officer (“CFO”).
FluoGuide A/S (“FluoGuide” or the “Company”) announce that the CFO of FluoGuide, Henrik Hang, has acquired 500 shares in the Company on 24 J...
Copenhagen, Denmark, 9 January 2023 - FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce the positive interim result of FG0...
Copenhagen, Denmark, 24 November 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 3...
Copenhagen, Denmark, 21 November 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the company has enrolled th...
Copenhagen, Denmark, 8 November 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform that the first large scale batch fo...
Copenhagen, Denmark, 6 November 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that FG001 lights up in 5 out of ...
Copenhagen, Denmark, 20 October 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the first patient has now en...
Copenhagen, Denmark, 6 October 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform that the Principal Investigator, Chi...
Copenhagen, Denmark, 3 October 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform of presentation of the outstanding c...
Copenhagen, Denmark, 6 September 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has received ...
Copenhagen, Denmark, 31 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) has today appointed Henrik Hang as Chief Financial Office...
Copenhagen, Denmark, 30 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the company now has received ...
Copenhagen, Denmark, 25 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 30 ...
Copenhagen, Denmark, 24 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) provides an update on the clinical development of FG001.
Copenhagen, Denmark 23 August2022– FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has submitted a CT...
Copenhagen, Denmark, 22 August 2022. FluoGuide A/S ("FluoGuide" or the “Company”) is pleased to announce a publication of clinical data that...
Copenhagen, Denmark, 31 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 31 Mar...
Copenhagen, Denmark, 6 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) invites to a presentation of the results from the clinical tr...
To the shareholders of FluoGuide A/S
Copenhagen, Denmark, 01.04.2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that FG001 has been shown safe and wel...
Copenhagen, Denmark, 30 March 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby publishes its annual report for the fiscal year 20...
Copenhagen, Denmark, 29 March 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that based on the approved Incentiv...
Copenhagen, Denmark, 24 March 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has received app...
Copenhagen, Denmark, 18 March 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce a grant of total 945 KDKK to conduc...
Copenhagen, Denmark, 10 March 2022 – FluoGuide A/S (publ) a developer of surgical precision solutions within oncology (“FluoGuide” or the “C...
Copenhagen, Denmark, 17:31 CEST, 10 March 2022 – FluoGuide A/S (publ), a developer of surgical precision solutions within oncology (“FluoGui...
Copenhagen, Denmark, 22 December 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has submitted...
ABG Sundal Collier initiates equity research on FluoGuide
Copenhagen, Denmark, 15 November 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 3...
Copenhagen, Denmark, 10 November 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has selected ...
